ATAI Life Sciences's market cap is currently $395.75M. The company's EPS TTM is $-0.804; its P/E ratio is ―; ATAI Life Sciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 314.00K	$ 233.00K	$ 20.38M	$ 0.00	$ 0.00
Gross Profit	$ 314.00K	$ 65.00K	$ 20.33M	$ -24.00K	-
Operating Income	$ -125.47M	$ -144.79M	$ -135.81M	$ -104.16M	$ 1.57M
EBITDA	$ -36.31M	$ -135.01M	$ -120.28M	$ -92.12M	$ -17.47M
Net Income	$ -40.22M	$ -141.41M	$ -132.61M	$ -102.12M	$ -17.48M
Balance Sheet
Cash & Short-Term Investments	$ 179.26M	$ 273.11M	$ 362.27M	$ 97.25M	$ 30.06M
Total Assets	$ 293.48M	$ 305.44M	$ 414.17M	$ 111.55M	$ 62.12M
Total Debt	$ 19.14M	$ 15.12M	$ 743.00K	$ 2.18M	$ 157.00K
Net Debt	$ -25.89M	$ -175.50M	$ -361.52M	$ -95.07M	$ -29.91M
Total Liabilities	$ 49.16M	$ 300.42M	$ 405.12M	$ 16.18M	$ 2.48M
Stockholders' Equity	$ 242.96M	$ 260.74M	$ -348.14M	$ 90.82M	$ 58.75M
Cash Flow
Free Cash Flow	$ -84.71M	$ -105.49M	$ -64.37M	$ -20.82M	$ -7.87M
Operating Cash Flow	$ -84.12M	$ -104.47M	$ -63.25M	$ -20.77M	$ -7.85M
Investing Cash Flow	$ -53.30M	$ -86.85M	$ -81.28M	$ -28.27M	$ -9.03M
Financing Cash Flow	$ -8.36M	$ 20.79M	$ 409.86M	$ 113.05M	$ 40.39M

Currency in USD

ATAI Life Sciences Earnings and Revenue History

Income Statement >

ATAI Life Sciences Debt to Assets

Balance Sheet >

ATAI Life Sciences Cash Flow

Cash Flow >

ATAI Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing